Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K, Watanabe S, Ohtsubo A, Shoji S, Ishikawa D, Tanaka T, Nozaki K, Kondo R, Okajima M, Miura S, Tanaka J, Sakagami T, Koya T, Kagamu H, Yoshizawa H, Narita I.
Sato K, et al. Among authors: narita i.
BMC Cancer. 2016 Mar 15;16:222. doi: 10.1186/s12885-016-2271-8.
BMC Cancer. 2016.
PMID: 26979596
Free PMC article.